dr. Renée Bultijnck (PhD)

Our research team focuses on the role of rehabilitation interventions (e.g. exercise, nutrition, psychosocial care, medical screenings) in men with prostate cancer. 

A second topic of interest is the influence of cancer therapies on patients quality of life and methods to positively influence it, in particular in prostate, breast and lung cancer patients.
 

• Postdoctoral researcher, Ghent University, Faculty of Medicine and health sciences, Department of Radiotherapy and Experimental Cancer Research (2022-current)
• PhD Fellowship of Research Foundation Flanders (FWO), Ghent University, Faculty of Medicine and health sciences, Department of Radiotherapy and Experimental Cancer Research (2017-2022) 
• PhD Fellowship, Sydney University, Survivorship Research Group and Centre for Medical Psychology & Evidence-based Decision-making (2019-2020
• Scientific assistant, Ghent University, Faculty of Medicine and health sciences, Department of Radiotherapy and Experimental Cancer Research (2014-2017) 
• Master of Science in Health Education and Health Promotion at Ghent University (2012-2014)
• Bachelor in nutrition and dietetics at the college of higher education Ghent (2009-2012) 
   

• Exercise prescription dose for castrate-resistant prostate cancer patients: a phase I prescription dose escalation trial. World journal of urology. 2021;39(2):357-64.
• Clinical pathway improves implementation of evidence-based strategies for the management of androgen deprivation therapy-induced side effects in men with prostate cancer. BJU international. 2018;121(4):610-8.
• A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer. Cancers. 2020;12(1):132.
   

• Lab address: Department of Radiotherapy and Experimental Cancer Research, Corneel Heymanslaan 10; B-9000 Gent
• X (former Twitter)
• Researchgate 
• ORCID   
• Renée Bultijnck is interested to receive invitation for presentations or talks